World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
110
Citations
47342
World Ranking
5537
National Ranking
2987

Gary S. Sachs publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Gary S. Sachs sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 401 publications — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Gary S. Sachs D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Gary S. Sachs sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 110 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Gary S. Sachs is affiliated with Harvard University in the United States. Their research primarily falls within the field of Medicine, with a particular focus on Psychiatry and Mental Health. Additional subfields include Neurology, Geriatrics and Gerontology, Pharmacology, and Biological Psychiatry.

The scientist's work spans several main topics related to mental health and neurological conditions, including:

  • Bipolar Disorder and Treatment
  • Schizophrenia Research and Treatment
  • Electroconvulsive Therapy Studies
  • Neurological Disorders and Treatments
  • Pharmaceutical Practices and Patient Outcomes
  • Treatment of Major Depression
  • Tryptophan and Brain Disorders

Gary S. Sachs has published extensively, with significant contributions to the following venues:

  • Psychopharmacology Bulletin
  • Journal of Psychopharmacology
  • The Journal of Clinical Psychiatry
  • European Psychiatry

Selected recent papers authored or co-authored by Gary S. Sachs include:

  • "Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening," 2025, Psychopharmacology Bulletin
  • "Two randomized, double-blind, placebo-controlled trials and one open-label, long-term trial of brexpiprazole for the acute treatment of bipolar mania," 2021, Journal of Psychopharmacology
  • "Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice," 2025, Psychopharmacology Bulletin
  • "Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing," 2025, Psychopharmacology Bulletin
  • "Brief Report: Paroxetine in Younger and Adult Individuals at High Risk for Suicide," 2025, Psychopharmacology Bulletin

The scientist frequently collaborates with several colleagues, including:

  • Michael E. Thase
  • Alisa B. Busch
  • Richard G. Frank
  • Mark S. Bauer
  • Stephen R. Wisniewski

Best Publications

  • Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire.

    Robert M.A. Hirschfeld;Janet B.W. Williams;Robert L. Spitzer;Joseph R. Calabrese

  • Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder

    Manuel A R Ferreira;Michael C O'Donovan;Yan A Meng;Ian R Jones

  • A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression

    Joseph R. Calabrese;Charles L. Bowden;Gary S. Sachs;John A. Ascher

  • Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression

    Mauricio Tohen;Mauricio Tohen;Eduard Vieta;Joseph R Calabrese;Terence A. Ketter

  • Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression

    Gary S. Sachs;Andrew A. Nierenberg;Joseph R. Calabrese;Lauren B. Marangell

  • Long-term implications of early onset in bipolar disorder: Data from the first 1000 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

    Roy H Perlis;Sachiko Miyahara;Lauren B Marangell;Stephen R Wisniewski

  • A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Manic or Hypomanic Patients With Bipolar I Disorder

    Charles L. Bowden;Joseph R. Calabrese;Gary Sachs;Lakshmi N. Yatham

  • Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

    Roy H. Perlis;Michael J. Ostacher;Jayendra K. Patel;Lauren B. Marangell

  • A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder

    Joseph R. Calabrese;Charles L. Bowden;Gary Sachs;Lakshmi N. Yatham

  • Whole-genome association study of bipolar disorder

    P Sklar;J W Smoller;J Fan;J Fan;M A R Ferreira

  • The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

    Isabella Pacchiarotti;David J. Bond;Ross J. Baldessarini;Willem A. Nolen

  • Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

    Naomi M Simon;Michael W Otto;Stephen R Wisniewski;Mark Fossey

  • The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.

    Alan S. Bellack;Charles L. Bowden;Christopher R. Bowie;Matthew J. Byerly

  • A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder

    Joseph R. Calabrese;Trisha Suppes;Charles L. Bowden;Gary S. Sachs

  • Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program

    David J. Miklowitz;Michael W. Otto;Ellen Frank;Noreen A. Reilly-Harrington

  • Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)

    Gary S Sachs;Michael E Thase;Michael W Otto;Mark Bauer

  • Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.

    Mauricio Tohen;Mauricio Tohen;K. N. Roy Chengappa;Trisha Suppes;Carlos A. Zarate

  • Is bipolar disorder still underdiagnosed? Are antidepressants overutilized?

    S.Nassir Ghaemi;Gary S Sachs;Alice M. Chiou;Ananda K Pandurangi

  • Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression

    Charles B. Nemeroff;Dwight L. Evans;Laszlo Gyulai;Gary S. Sachs

  • Combination of a Mood Stabilizer With Risperidone or Haloperidol for Treatment of Acute Mania: A Double-Blind, Placebo-Controlled Comparison of Efficacy and Safety

    Gary S. Sachs;Fred Grossman;S. Nassir Ghaemi;Akiko Okamoto

Frequent Co-Authors

Michael E. Thase
Michael E. Thase University of Pennsylvania
Andrew A. Nierenberg
Andrew A. Nierenberg Harvard University
Joseph R. Calabrese
Joseph R. Calabrese Case Western Reserve University
David J. Miklowitz
David J. Miklowitz University of California, Los Angeles
Charles L. Bowden
Charles L. Bowden The University of Texas Health Science Center at San Antonio
Roy H. Perlis
Roy H. Perlis Harvard University
Jerrold F. Rosenbaum
Jerrold F. Rosenbaum Harvard University
Terence A. Ketter
Terence A. Ketter Stanford University
Stephen R. Wisniewski
Stephen R. Wisniewski University of Pittsburgh
Mark H. Pollack
Mark H. Pollack Rush University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online healthcare degrees can open up new career pathways, whether you’re aiming to work in clinical care or healthcare administration. Many students who consider studying Medicine in the USA are also interested in related advanced nursing and management programs. For those seeking a rapid transition into specialized mental health fields, shortest post master's pmhnp online programs offer a fast track to becoming a Psychiatric Mental Health Nurse Practitioner.

Cost is a key concern when pursuing higher education. If you are considering a leadership or administrative career, finding a program that fits your budget is crucial. Learn more about healthcare administration degree cost and explore your options for affordable, reputable training. Those looking for graduate degrees in administration should review some of the most cheap mha programs available online.

Advanced practitioners and future leaders may also benefit from exploring cheap dnp online programs—a smart choice for those aiming for the highest levels in clinical nursing practice without incurring excessive debt. Carefully comparing program costs, flexibility, and accreditation will help you find the best fit for your goals.

Best Scientists Citing Gary S. Sachs

Trending Scientists

Recently Published Articles